Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING IMMUNE DISEASES, INCLUDING AMNIOTIC FLUID STEM CELLS OR CULTURE MEDIUM THEREOF
Document Type and Number:
WIPO Patent Application WO/2014/115912
Kind Code:
A1
Abstract:
The present invention provides a pharmaceutical composition for preventing and treating autoimmune diseases or immune dysfunction-related diseases, including amniotic fluid derived stem cells having an immunoregulatory function or a culture medium thereof.

Inventors:
SHON YUN HEE (KR)
YOO JAMES J (US)
SUH JANG SOO (KR)
Application Number:
PCT/KR2013/000608
Publication Date:
July 31, 2014
Filing Date:
January 25, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYUNGPOOK NAT UNIV HOSPITAL (KR)
International Classes:
C12N5/071; A61K35/14; A61P37/00
Domestic Patent References:
WO2012014247A12012-02-02
Other References:
MIRABELLA, TEODELINDA ET AL.: "Recruitment of host's progenitor cells to sites of human amniotic fluid stem cells implantation", BIOMATERIALS, vol. 32, no. 18, 2 April 2011 (2011-04-02), pages 4218 - 4227
SESSAREGO, NADIA. ET AL.: "Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application", HAEMATOLOGICA, vol. 93, no. 3, 11 February 2008 (2008-02-11), pages 339 - 346
TEODELINDA, MIRABELLA ET AL.: "Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model", BIOMATERIALS, vol. 32, no. 15, 2 March 2011 (2011-03-02), pages 3689 - 3699
LINDENMAIR, ANDREA ET AL.: "Mesenchymal Stem or Stromal cells from Amnion and umbilical cord tissue and their potential for clinical applications", CELLS, vol. 1, no. 4, 12 November 2012 (2012-11-12), pages 1061 - 1088
Attorney, Agent or Firm:
LEE, DUCK-ROG (KR)
이덕록 (KR)
Download PDF: